Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
Kendler, D.L., Bone, H.G., Massari, F., Gielen, E., Palacios, S., Maddox, J., Yan, C., Yue, S., Dinavahi, R.V., Libanati, C., Grauer, A.
Published in Osteoporosis international (01.12.2019)
Published in Osteoporosis international (01.12.2019)
Get full text
Journal Article